U.S., Aug. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07137819) titled 'Phase 3 - Evaluation of Veregen(R) 10% Ointment as New Herbal Topical Treatment for Actinic Keratosis' on Aug. 15.
Brief Summary: The goal of this clinical trial is to show superiority of Veregen(R) 10% ointment to Placebo measured by complete (100%) clearance of a pre-defined treatment area (TA) following a treatment period of 12 weeks and a 4-weeks post-treatment (PT) period (i.e., after 16 weeks at most in patients without complete clearance at the end of the treatment (EoT) period).
Study Start Date: Sept. 04, 2024
Study Type: INTERVENTIONAL
Condition:
Actinic Keratosis of Face and Scalp
Intervention:
DRUG: Topical treatme...